Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enfuvirtide induction in heavily treatment-experienced HIV patients
2004-000532-85Phase 4Completed
- Sponsor
- North Manchester General Hospital
- Start
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of enfuvirtide in human immunodeficiency virus infection (HIV), sponsored by North Manchester General Hospital. Primary endpoints: Virological failure and CD4+ count increase and viral load decrease. Started Feb 2005; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-000532-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000532-85.